OS Therapies Incorporated(OSTX)
$0.87-0.02 (-2.02%)
OSTX
OS Therapies Incorporated financials statements
$0.87
At close:-0.02 (-2.02%)
Want to see OSTX full AI Analyst Report?
OS Therapies Incorporated (OSTX) Ratios
269 Followers
OS Therapies Incorporated Ratios
OSTX's free cash flow for Q2 2026 was $-5.53M. For the 2026 fiscal year, OSTX's free cash flow was increased by $0.00 and operating cash flow was $-5.53M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.03 | 1.20 | 0.03 | 0.08 | 0.09 |
| Quick Ratio | 0.03 | 1.20 | 0.03 | 0.08 | 0.09 |
| Cash Ratio | 0.02 | 1.20 | 0.00 | 0.03 | 0.02 |
| Solvency Ratio | -2.19 | -1.88 | -0.31 | -0.35 | -0.63 |
| Operating Cash Flow Ratio | -1.21 | -1.57 | -0.12 | -0.62 | -1.26 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -0.21 | 0.00 | 0.00 |
| Net Current Asset Value | $ -12.60M | $ 806.22K | $ -24.02M | $ -17.57M | $ -11.46M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 18.31 | 20.33 | 21.70 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | -0.61 | -0.59 | -0.62 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | -1.55 | -1.44 | -1.62 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | -1.44 | -1.62 |
| Financial Leverage Ratio | -1.12 | 6.83 | -0.03 | -0.03 | -0.03 |
| Debt Service Coverage Ratio | 0.00 | -3.33 | -0.24 | -2.46 | -1.87 |
| Interest Coverage Ratio | 0.00 | -3.32 | -1.26 | -2.46 | -1.87 |
| Debt to Market Cap | 0.00 | 0.00 | 0.29 | 0.18 | 0.12 |
| Interest Debt Per Share | 0.00 | 0.10 | 0.90 | 0.53 | 0.42 |
| Net Debt to EBITDA | 0.01 | 0.81 | -3.36 | -2.29 | -1.45 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 100.17% | 130.37% | 179.42% | 140.67% | 153.39% |
| Return on Assets (ROA) | -420.41% | -160.38% | -976.29% | -1228.56% | -2276.91% |
| Return on Equity (ROE) | 471.71% | -1094.65% | 32.44% | 35.62% | 64.80% |
| Return on Capital Employed (ROCE) | 582.87% | -747.55% | 18.16% | 78.85% | 152.58% |
| Return on Invested Capital (ROIC) | 582.87% | -747.55% | 46.67% | 78.85% | 152.58% |
| Return on Tangible Assets | -8572.95% | -160.38% | -976.29% | -1228.56% | -2276.91% |
| Earnings Yield | -70.21% | -9.94% | -15.48% | -10.79% | -12.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.04 | 0.00 | 0.00 | 0.00 | 1.35 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -9988.79 | -218221.16 | -234862.71 | -555495.54 | -269.59 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 9988.79 | 218221.16 | 234862.71 | 555495.54 | 269.59 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.49 | -0.35 | -0.15 | -0.16 | -0.19 |
| Free Cash Flow Per Share | -0.49 | -0.35 | -0.15 | -0.16 | -0.19 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -0.23 | 0.00 | 0.00 | -368.93 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -368.93 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -0.21 | -0.37 | -0.62 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -34.77% | -8.15% | -5.98% | -6.54% | -7.61% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.43 | -8.23 | -6.46 | -9.27 | -7.81 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -6.72 | 110.07 | -2.10 | -3.30 | -5.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.88 | -12.27 | -16.74 | -15.29 | -13.13 |
| Price-to-Operating Cash Flow Ratio | -2.88 | -12.27 | -16.74 | -15.29 | -13.17 |
| Price-to-Earnings Growth (PEG) Ratio | -0.02 | -0.25 | -0.16 | 0.61 | -0.00 |
| Enterprise Value Multiple | -1.43 | -12.27 | -14.96 | -15.33 | -13.43 |
| Enterprise Value | 40.68M | 83.79M | 64.90M | 68.16M | 64.97M |
| EV to EBITDA | -1.43 | -12.27 | -14.96 | -15.33 | -13.43 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -2.86 | -11.51 | -21.58 | -17.97 | -14.72 |
| EV to Operating Cash Flow | -2.86 | -11.51 | -21.58 | -17.97 | -14.76 |
| Tangible Book Value Per Share | -0.43 | 0.04 | -1.20 | -0.76 | -0.50 |
| Shareholders’ Equity Per Share | -0.21 | 0.04 | -1.20 | -0.76 | -0.50 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.98 | -0.43 | -0.39 | -0.27 | -0.32 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.30 | 1.79 | 1.41 | 1.53 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.50 | 0.82 | 0.39 | 0.61 | 0.59 |
Currency in USD
